Sun Pharma Advanced Research Company Company Description

Sun Pharma Advanced Research Company Limited, a clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally.

It develops products with a therapeutic focus on oncology and immunology. The company is also developing Vodobatinib (SCO-088), a BCR-ABL inhibitor, for the treatment of refractory chronic myelogenous leukemia that is in phase 2 clinical trial; and Vibozilimod (SCD-044), a selective sphingosine-1-phosphate receptor 1 (S1PR1) agonist, for the treatment of psoriasis and atopic dermatitis that is in phase 2 clinical trial.

In addition, it develops SCD-153 for the treatment of alopecia areata; and SBO-154, an anti-MUC-1 ADC, for the treatment of multiple tumors that is in preclinical trials.

The company was incorporated in 2006 and is based in Mumbai, India.

Sun Pharma Advanced Research Company Limited

Country	India
Founded	2006
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	316
CEO	Anilkumar Raghavan

Contact Details

Address: 17/B, Mahal Industrial Estate Mumbai, 400093 India
Phone	91 22 6645 5645
Website	sparc.life

Stock Details

Ticker Symbol	SPARC
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE232I01014
SIC Code	2834

Key Executives

Name	Position
Anilkumar Raghavan	Chief Executive Officer
Anup Rathi	Chief Financial Officer
Dr. Nitin Dharmadhikari	Chief Operating Officer
Jaydeep Issrani	Senior General Manager of Business Development, Corporate Communication and Investor Relations
Kajal K. Damania	Company Secretary and Compliance Officer
Shanta Gupta	Chief Human Resource Officer
Siu-Long Yao	Head Clinical Development
Dr. Nitin K. Damle Ph.D.	Executive Vice President of Biologics and Chief Innovation Officer
Dr. Yashoraj Zala	Head of Drug Delivery Systems
Dr. Vikram K. Ramanathan	Head of Drug Discovery and Preclinical Development